Company Flamel Technologies S.A. (ADR) Nasdaq
Equities
US3384881096
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
07-01 | Avadel Pharmaceuticals plc(NasdaqGM:AVDL) added to Russell Small Cap Completeness Index | CI |
07-01 | Avadel Pharmaceuticals plc(NasdaqGM:AVDL) added to Russell 2000 Index | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Thomas McHugh
DFI | Director of Finance/CFO | 59 | 19-12-01 |
Scott Macke
COO | Chief Operating Officer | - | 14-08-31 |
Jerad G. Seurer
CMP | Compliance Officer | - | 16-12-31 |
Jennifer Gudeman
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-06 |
Jason Vaughn
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-01 |
Denise Strauss
SAM | Sales & Marketing | - | 21-06-01 |
Angela Woods
HRO | Human Resources Officer | - | 21-04-30 |
Richard Kim
PRN | Corporate Officer/Principal | 54 | 21-02-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Ende
BRD | Director/Board Member | 55 | 18-11-30 |
Gregory Divis
CEO | Chief Executive Officer | 57 | 17-01-02 |
Mark McCamish
BRD | Director/Board Member | 72 | 19-12-04 |
Geoffrey Glass
CHM | Chairman | 50 | 18-06-30 |
Linda Palczuk
BRD | Director/Board Member | 62 | 18-06-30 |
Peter Thornton
BRD | Director/Board Member | 59 | 17-06-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 96,118,523 | 91,588,806 ( 95.29 %) | 0 | 95.29 % |
Stock B | 0 | 5,194,000 | 0 | 0 |
Company contact information
![address Flamel Technologies S.A. (ADR)](https://cdn.zonebourse.com/static/address/9315.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+62.12% | 856B | |
+38.95% | 631B | |
-4.07% | 359B | |
+15.39% | 325B | |
+9.01% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+16.06% | 177B | |
+2.31% | 165B |
- Stock Market
- Equities
- AVDL Stock
- Stock
- Company Flamel Technologies S.A. (ADR)